FRENOVO Benzodiazepines (BZO) Rapid Test is a lateral flow, qualitative immunoassay. It is intended for qualitative detection of Oxazepam, a Benzodiazepines metabolite with a minimum detection concentration of 300 ng / ml in human urine samples, and for the preliminary screening detection of Benzodiazepines.
Clinical sensitivity = 93.33 %
Clinical specificity =98.00 %
Accuracy= 95.67 %
Description：Benzodiazepines (BZO) Cassette
Method：GICA
Packing：20 Tests/Box
Specimen：Urine
English
